A detailed history of Clarkston Capital Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Clarkston Capital Partners, LLC holds 6,500 shares of BSX stock, worth $594,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,500
Previous 6,500 -0.0%
Holding current value
$594,750
Previous $500,000 8.8%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$35.24 - $47.1 $5,391 - $7,206
-153 Reduced 2.3%
6,500 $242,000
Q1 2022

May 09, 2022

BUY
$40.9 - $45.1 $6,257 - $6,900
153 Added 2.35%
6,653 $295,000
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $229,255 - $257,855
6,500 New
6,500 $251,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Clarkston Capital Partners, LLC Portfolio

Follow Clarkston Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarkston Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarkston Capital Partners, LLC with notifications on news.